THE IMPORTANCE OF PHARMACEUTICAL INTERVENTION TO DIABETIC PATIENTS ATTENDED AT THE STATE CENTER FOR SPECIALIZED ATTENTION (CEAE) OF TEOFILO OTONI-MG AT RISK OF CHRONIC KIDNEY DISEASE DEVELOPMENT

Abstract

The present study aimed to evaluate the impact of pharmacotherapeutic follow-up on patients with diabetes mellitus at risk of developing kidney disease and its implications for these patients. This is a prospective intervention study, in which 1600 medical records of patients diagnosed with DM2 were selected, considered to be at high risk, that is, they had glycated hemoglobin A1C values greater than 9%, and creatinine> 1.2 mg / dl, linked to the clinical office of the State Center for Specialized Care - CEAE - in the municipality of Teófilo Otoni - MG. Patients received pharmacotherapeutic follow-up with individual guidance, for a period of not less than 6 months or at least 03 consultations. The biochemical parameters related to glycated hemoglobin and plasma creatinine were collected from medical records. In the present study, there was a significant increase in adherence and knowledge of treatment after pharmacotherapeutic monitoring. Regarding the epidemiological profile, in relation to the gender variable, it verifies, about 75%, that is, 1,245 participants are male and 25%, that is, 365 of the patients are female, in terms of age, it was found that 768 users (48%), are in the economically active range of 40 - 60 years. Biochemical standards show that 95%, about 1520 of diabetic patients, after 6 months of follow-up presented glycated hemoglobin within the parameters marked by the Brazilian Society of Diabetics, that 30% of the samples, 480 users were referred to the program with index creatinine levels greater than 1.2 mg / dl and with serious risks of renal impairment, fluctuations in prolonged hyperglycemia and the development of diabetes complications responsible for tissue damage, loss of function and organ failure, after monitoring, a reduction of para levels below 1.2 mg-dl in about 80 (5%) of diabetic patients who had creatine levels greater than 1.2 mg / dl. In conclusion, the data show that the population studied, composed of diabetic patients referred to CEAE and considered to 3 be at high risk for developing renal functional failure, need special care for the clinical control of their diseases. The results show that, with regard to diabetic patients who received monitoring of hemoglobin and creatinine parameters, through pharmacotherapeutic monitoring, they showed improvements and reduced rates, consequently early interventions allow to prevent or delay their clinical evolution. Key words: Type 2 diabetes mellitus. Risk. Pharmaceutical attention. Retinopathy.